Published

Renal excretion profiles of psilocin following oral administration of psilocybin: a controlled study in man

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Pharmaceutical and Biomedical Analysis
Date: 2002-09-01
Source: Crossref
DOI: 10.1016/s0731-7085(02)00278-9
PubMed: 12191719

Authors

Hasler Felix Bourquin Daniel Brenneisen Rudolf Vollenweider Franz X

Watch author

Derived topics and classifications

psilocybin psilocin General Other

Citation graph

17 referenced DOIs found in stored source metadata. 20 indexed papers cite this DOI.

Open citation network

10.1016/0378-8741(92)90020-r 10.1111/j.1360-0443.1992.tb02696.x 10.1080/07448481.1994.9936359 10.1016/0006-3223(95)00418-1 10.1016/s0893-133x(96)00246-1 10.1097/00008877-199811000-00011 10.1055/s-2007-979353 10.1097/00001756-199812010-00024 10.1016/s0893-133x(98)00089-x 10.1007/s002130050860 10.1016/s0893-133x(98)00108-0 10.1016/s0031-6865(97)00014-9

Indexed papers citing this DOI

Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe Anxiety2026-08-12 Rapid and Sensitive Detection of Psilocybin and Psilocin in Urine by Surface-Enhanced Raman Spectroscopy2026-05-28 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23 Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain Exposure2026-02-12 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01 In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29 Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry2024-03-01 Development and validation of a sensitive LC-MS-MS method to quantify psilocin in authentic oral fluid samples2023-12-12 Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2021-02-01 Exposure-Response Analysis to Assess the Concentration-QTc Relationship of Psilocybin/Psilocin2021-01-01 Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms2020-10-01 Direct Analysis of Psilocin and Muscimol in Urine Samples Using Single Drop Microextraction Technique In-Line with Capillary Electrophoresis2020-03-29 Psilocin and ketamine microdosing: effects of subchronic intermittent microdoses in the elevated plus-maze in male Wistar rats2018-09-01 Metabolism of psilocybin and psilocin: clinical and forensic toxicological relevance2017-01-02 Effect of Psilocin on Extracellular Dopamine and Serotonin Levels in the Mesoaccumbens and Mesocortical Pathway in Awake Rats2015-01-01 Fungal Hallucinogens Psilocin, Ibotenic Acid, and Muscimol2013-08-01 Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS/MS2013-05-01 A validated method for quantitation of psilocin in plasma by LC-MS/MS and study of stability2012-11-01 Glucuronidation of Psilocin and 4-Hydroxyindole by the Human UDP-Glucuronosyltransferases2010-03-01 Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a “magic mushroom” user2006-07-01